NYMC Faculty Publications
Hemolysis in Early Infancy: Still a Cause of Cholestatic Neonatal Giant Cell Hepatitis
Author Type(s)
Faculty
DOI
10.1097/PAS.0000000000001841
Journal Title
The American Journal of Surgical Pathology
First Page
801
Last Page
808
Document Type
Article
Publication Date
6-1-2022
Department
Pediatrics
Abstract
Before the prophylactic use of anti-D antibodies in pregnancy, hemolytic anemia of the newborn was the most common cause of hyperbilirubinemia. Nowadays, given the rarity of hemolytic anemia of the newborn, hepatobiliary abnormalities, perinatal infections, and metabolic disorders have become the most common conditions in the differential diagnosis of neonatal cholestasis. Here, we report 3 instances of cholestatic giant cell hepatitis in 3 infants who had Coombs' positive hemolysis due to ABO incompatibility in 1, Rh incompatibility in another, and combined ABO and Rh incompatibility in the third. Although rare, cholestatic neonatal giant cell hepatitis associated with hemolysis still needs to be considered in patients with neonatal cholestasis. A marked elevation of aspartate aminotransferase over alanine aminotransferase can be a helpful clue to an early diagnosis.
Recommended Citation
Wu, H., Tugal, O., & Perez-Atayde, A. R. (2022). Hemolysis in Early Infancy: Still a Cause of Cholestatic Neonatal Giant Cell Hepatitis. The American Journal of Surgical Pathology, 46 (6), 801-808. https://doi.org/10.1097/PAS.0000000000001841